Oculis
Samia Reffas Jobin is a seasoned professional in pharmacovigilance with extensive experience in the pharmaceutical industry. Currently serving as Senior Director and Head of Pharmacovigilance at Oculis since October 2024, Samia previously held the position of Medical Safety Director at Galapagos from October 2021 to October 2024. Prior roles include Process Excellence Specialist and Senior Safety Scientist at United Biosource Corporation (UBC) from November 2012 to October 2021, and Manager of Global Drug Safety at Merck Serono from February 2008 to October 2012. Samia holds a Doctor of Philosophy (Ph.D.) in Molecular Biology from the Faculty of Medicine at the University of Geneva, attained from 1995 to 2000.
This person is not in any teams
Oculis
1 followers
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.